The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

CA 125 levels w/in normal range being studied for predicitng recurrence

sleem
sleem CSN Member Posts: 92
A few articles are out there for UPSC uterine & ovarian @ different stages discussing CA 125 rising in a certain manner for demonstrating recurrence.
Question: Some doctors using 3 or more progressively rising CA-125 values doubling from a nadir (certin comparison starting CA 125) as a precautioner for cancer returning before it can show up on scans as it is too small to see at that point. Two ideas- Some are starting chemo after this 'certain' number CA-125 doubles other doctors do not do so.

Any first-hand info you experienced or heard about?

Comments

  • Rewriter
    Rewriter CSN Member Posts: 493 Member
    New study
    My gyne-oncologist said that new studies indicate that starting chemo after CA-125 doubles a few times beyond a normal value does not provide a survival benefit. Instead, chemo can be started once recurrence appears on a CT/PET scan.
  • sleem
    sleem CSN Member Posts: 92
    Rewriter said:

    New study
    My gyne-oncologist said that new studies indicate that starting chemo after CA-125 doubles a few times beyond a normal value does not provide a survival benefit. Instead, chemo can be started once recurrence appears on a CT/PET scan.

    me too
    I've read some studies. I feel it is too new yet. However, I believe this will be a means in the future once all the research is in perhaps. I like the idea of starting before a scan can see it. Thanks for sharing Rewriter.